⚠️ This provider averages 980 services per working day — physically unusual for an individual practitioner
Based on 2.4M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $37.5M in total Medicare payments ranks in the 99th percentile of Rheumatology providers nationally.
Averaging 980 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $32.11 | $17.64 | 1.82x | $14.47 | $3.0M | 167.5K | 64 |
| 2015 | $28.30 | $16.44 | 1.72x | $11.86 | $3.5M | 210.5K | 67 |
| 2016 | $31.21 | $18.89 | 1.65x | $12.32 | $3.9M | 208.1K | 63 |
| 2017 | $28.63 | $18.22 | 1.57x | $10.41 | $4.2M | 233.1K | 53 |
| 2018 | $28.71 | $18.23 | 1.57x | $10.48 | $4.1M | 223.1K | 57 |
| 2019 | $29.53 | $17.46 | 1.69x | $12.07 | $4.3M | 244.3K | 56 |
| 2020 | $28.10 | $15.76 | 1.78x | $12.34 | $3.7M | 236.7K | 58 |
| 2021 | $29.65 | $15.28 | 1.94x | $14.37 | $4.1M | 265.3K | 59 |
| 2022 | $24.66 | $10.92 | 2.26x | $13.74 | $3.4M | 308.4K | 55 |
| 2023 | $22.55 | $9.82 | 2.30x | $12.73 | $3.5M | 352.7K | 54 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 200.2K | $10.2M | $51.15 | 1.94x |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 249.6K | $9.0M | $36.16 | 1.46x |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.4M | $7.4M | $5.38 | 1.82x |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 143.4K | $2.1M | $14.71 | 1.83x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 14.9K | $1.3M | $85.15 | 1.48x |
| J0897 | Injection, denosumab, 1 mg | 78.3K | $1.1M | $14.67 | 1.47x |
| J9310 | Injection, rituximab, 100 mg | 1.3K | $724.8K | $575.25 | 1.39x |
| J3262 | Injection, tocilizumab, 1 mg | 127.7K | $570.9K | $4.47 | 1.71x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 5.1K | $567.1K | $111.50 | 1.93x |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | 26.6K | $527.2K | $19.86 | 2.12x |
| J9312 | Injection, rituximab, 10 mg | 7.5K | $524.6K | $69.94 | 1.43x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 5.0K | $307.2K | $61.49 | 1.45x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 5.0K | $283.9K | $56.45 | 2.21x |
| 82784 | Gammaglobulin (immune system protein) measurement | 18.3K | $172.5K | $9.40 | 1.60x |
| 96372 | Injection of drug or substance under skin or into muscle | 10.7K | $159.3K | $14.90 | 2.35x |
| 96415 | Administration of chemotherapy into vein, each additional hour | 6.2K | $148.9K | $24.16 | 3.93x |
| 20610 | Aspiration and/or injection of fluid from large joint | 2.7K | $115.1K | $42.30 | 2.48x |
| 83520 | Measurement of substance using immunoassay technique | 6.6K | $113.4K | $17.09 | 1.46x |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | 1.7K | $108.4K | $62.45 | 2.32x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 812 | $99.6K | $122.61 | 1.50x |
This provider submits charges 1.82 times higher than what Medicare actually pays.
A markup ratio of 1.82x means for every $100 Medicare pays, this provider initially charges $182. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Rheumatology providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Barry Eibschutz, M.D. | San Luis Obispo, CA | $55.8M | ✓ Clear |
| Shariar Cohen-Gadol, M.D. | Thousand Oaks, CA | $49.5M | ⚠️ Flagged |
| Gerald Ho, M.D. | La Palma, CA | $45.8M | ✓ Clear |
| Arash Horizon, M.D. | Los Angeles, CA | $45.0M | ✓ Clear |
| Daniel Watrous, M.D. | Visalia, CA | $41.6M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data